Scarica l'app Stockscreener
3.02
23.01%
0.565
Dopo l'orario di chiusura:
2.98
-0.04
-1.32%
Absci Corp Borsa (ABSI) Ultime notizie
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday - Benzinga
Absci (NASDAQ:ABSI) Given "Buy" Rating at Needham & Company LLC - MarketBeat
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements - Benzinga
Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings) - Benzinga
ADAR1 Capital Management LLC Has $413,000 Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
Raymond James Financial Inc. Makes New Investment in Absci Co. (NASDAQ:ABSI) - MarketBeat
Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market - Seeking Alpha
Top 5 AI & Digital Biotech Companies (April 2025) - Securities.io
Absci stock touches 52-week low at $2.45 amid market challenges - Investing.com
Absci stock touches 52-week low at $2.45 amid market challenges By Investing.com - Investing.com South Africa
Which Healthcare Stock Is the Best Buy Right Now? - MarketBeat
Absci to Participate in Upcoming Investor Conferences - MarketScreener
AI Drug Pioneer Absci Takes Center Stage at Two Elite Healthcare Conferences - Stock Titan
Royce & Associates LP Grows Stake in Absci Co. (NASDAQ:ABSI) - MarketBeat
HC Wainwright Issues Negative Estimate for Absci Earnings - MarketBeat
Absci Corp’s Earnings Call: Balancing Innovation and Financial Challenges - MSN
KeyBanc maintains Absci stock Overweight rating, $5 target By Investing.com - Investing.com South Africa
KeyBanc maintains Absci stock Overweight rating, $5 target - Investing.com
Platinum Investment Management Ltd. Boosts Holdings in Absci Co. (NASDAQ:ABSI) - MarketBeat
Absci (NASDAQ:ABSI) Earns Buy Rating from Guggenheim - MarketBeat
Absci (NASDAQ:ABSI) Given "Buy" Rating at HC Wainwright - MarketBeat
Absci (NASDAQ:ABSI) Given Buy Rating at Needham & Company LLC - MarketBeat
Absci (NASDAQ:ABSI) Releases Quarterly Earnings Results - MarketBeat
Absci (NASDAQ:ABSI) Announces Earnings Results - MarketBeat
Absci Corporation (NASDAQ:ABSI) Q4 2024 Earnings Call Transcript - Insider Monkey
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Benzinga
Absci Corp (ABSI) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus
Nikko Asset Management Americas Inc. Boosts Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
H.C. Wainwright maintains $7 target on Absci stock with Buy rating - Investing.com Australia
Earnings call transcript: Absci Q4 2024 revenue misses, stock dips By Investing.com - Investing.com Australia
Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
A Glimpse Into The Expert Outlook On Absci Through 7 Analysts - Benzinga
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga India
Absci Corp (ABSI) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ... By GuruFocus - Investing.com Canada
Absci Corp. Reports 2024 Earnings and Strategic Advances - TipRanks
Earnings call transcript: Absci Q4 2024 revenue misses, stock dips - Investing.com
Absci earnings missed by $0.03, revenue fell short of estimates - Investing.com
Absci Corp reports results for the quarter ended December 31Earnings Summary - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Absci shares tumble as Q4 revenue falls short of estimates - Investing.com
Absci Corp SEC 10-K Report - TradingView
Absci reports Q4 EPS (25c), consensus (22c) - TipRanks
3.44%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):